RCE in Sourcecodester Drug Recommendation System
CVE-2026-94034
A vulnerability was found in SourceCodester Drug Recommendation System 1.0. This issue affects some unknown processing of the file /drug_recommender/Admin/change_password of the component Password Change. Performing a manipulation of the argument txtoldpassword/txtnewpassword results in cross site scripting. The attack can be initiated remotely. The exploit has been made public and could be used.
Vulnerability class: XSS (Cross-Site Scripting)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 3.5 (Low). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N.
EPSS exploit prediction
EPSS: 0.003 (28.5th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 28th percentile — 28.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000
Affected products
- Sourcecodester Drug Recommendation System — versions 1.0
Weakness classification (CWE)
References
- github.com/KaranParelkar/Drug_recommendation_system/blob/main/xss/change_passwo… (exploit)
- vuldb.com/cve/CVE-2026-94034 (third-party-advisory)
- vuldb.com/submit/946175 (third-party-advisory)
- vuldb.com/vuln/407962 (technical-description, vdb-entry)
- vuldb.com/vuln/407962/cti (signature, permissions-required)
- www.sourcecodester.com/ (product)
Frequently asked questions
- What is CVE-2026-94034?
- CVE-2026-94034 is a low-severity vulnerability in Sourcecodester Drug Recommendation System, classified under Cross-site Scripting. CVSS score: 3.5/10. Published 2026-09-20.
- How severe is CVE-2026-94034?
- Low severity. CVSS v3 base score is 3.5 out of 10.